Will Stone
-
The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people.
-
Until recently, plants from only one U.S. facility were approved for use in research. Adding new suppliers will accelerate understanding of cannabis' health effects and possible therapeutic uses.
-
Many Americans are still making sense of new CDC guidance that vaccinated people no longer have to wear masks in most indoor settings.
-
With older adults vaccinated, doctors say a growing share of their COVID-19 patients are in their 20s, 30s, 40s and 50s, as more contagious variants circulate among people who are still unvaccinated.
-
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs.
-
Glitchy websites, jammed phone lines and long lines outside clinics are complicating the vaccine rollout. And older Americans and those without caregivers and computer skills are at a disadvantage.
-
COVID-19 has now killed more Americans than WWII. That fact helps some people put the viral death toll in perspective, while others find it offensive. Historically, is it even a valid comparison?
-
Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems.
-
Although vaccination has begun, this winter has been the deadliest season of the pandemic. The U.S. death toll jumped from 300,000 to 400,000 in just five weeks.
-
The people who got the first coronavirus vaccine shots in the U.S. are now getting their second doses, required for maximum protection.